Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Tenet HealthcareTHC |
$8,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gerald Moran Republican | Dec 14, 2023 | Sell | $1K - $15K |
| Gerald Moran Republican | Dec 14, 2023 | Sell | $1K - $15K |
| Thomas Tuberville Republican | Dec 12, 2023 | Sell | $1K - $15K |
| Rohit Khanna Democrat | Jun 29, 2023 | Sell | $1K - $15K |
| Rohit Khanna Democrat | May 19, 2023 | Buy | $1K - $15K |
| Rohit Khanna Democrat | Mar 24, 2023 | Sell | $1K - $15K |
| Rohit Khanna Democrat | Feb 14, 2023 | Buy | $1K - $15K |
Who is the latest politician to buy or sell DaVita shares?
Gerald Moran sold DaVita shares most recently on December 14, 2023.
Which politician has bought the most DVA stock in the last two years?
Rohit Khanna has bought the most DVA stock in the last 2 years, with an estimated value of $16,000.
Which politician has sold the most DVA stock over the last two years?
Rohit Khanna has sold the most DVA stock in the last 2 years, with an estimated value of $16,000.
What is the total value of politicians trading DVA stock in the last 2 years?
The net value of trades by US politicians for DaVita in the last 2 years is negative, amounting to -$24,000. This suggests that US politicians do not believe in the success of the company for various reasons.
How do insider transactions over the last 2 years reflect on DaVita's market confidence?
Over the last 2 years, insider transactions for DaVita have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
